 With regards to measuring cardiovascular outcomes of cardiac output and stroke volume, the investigators plan to use a novel non-invasive monitor which is based on the phenomenon of bioreactance that occurs when a small alternating current is passed through the chest. To the investigators knowledge this device has never been used when assessing cardiovascular response to beta-blockers during exercise, but it is safe and easy to perform at the same time as the standard exercise test. 